| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |